InvestorsHub Logo
Followers 10
Posts 1117
Boards Moderated 0
Alias Born 05/16/2008

Re: in it to win it post# 7858

Friday, 09/03/2010 10:14:45 AM

Friday, September 03, 2010 10:14:45 AM

Post# of 19500
ACM posted a response which I dont know if I fully agree with but it would give an absolute worst case scenario. He suggested that you do the anaylysis with the fully diluted number of shares (1.6 billion I believe). My problem with that is that its not quite apples to apples. At this time approx 1/2 are issued ( 800 mill) in rough numbers. And we are making our analysys based on revenue expectations for 12 or 15 months from now. So unless we expect Pat to convert all shares within that time period ( which I hope is not the case) then these numbers are incredibly conservative.


So,
2,430,000 + 13,824,000 = 16,254,000 net profit from Attrius and PA.

16,254,000 % 1.6 billion (total shares outstanding) = .0101

.0101 * PE of 10 = .1015
.0101 * PE of 15 = .1524
.0101 * PE of 20 = .2032 on a fully diluted basis. So I would suggest somewhere inbetween.

At PE of 15 = (.1524 + .315) / 2 = .2337
At PE of 20 = (..2032 + .42 / 2 = .3116

Also as noted, world wide sales and revenue from drugs and maintenance of equipment is not included